Showing results (221-230 of 946) with videos related to

Sort By:
Pageof 95
Journal of Neurochemistry|September 1, 1989
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigraH Saggu, J Cooksey, D Dexter, et al.
Drug Design and Delivery|December 1, 1987
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugsH Van de Waterbeemd, B Testa, C Marrel, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1987
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized miceD R Cooper, C Marrel, H van de Waterbeemd, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1987
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's diseaseD R Cooper, C Marrel, H van de Waterbeemd, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Mitochondrial DNA analysis in Parkinson's diseaseA H Schapira, I J Holt, M Sweeney, et al.
Neuroreport|October 3, 1994
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazoleG M MacKenzie, S Rose, P A Bland-Ward, et al.
European Journal of Pharmacology|April 24, 1995
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmosetK K Gnanalingham, N A Milkowski, L A Smith, et al.
Pageof 95